Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

The United Kingdom is establishing a new biosecurity center designed to improve research into potentially pandemic-causing ...

BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

Intuitive Surgical is showing off the remote capability of its robots, with a transatlantic demonstration hosted by the ...

To secure the antibody, I-Mab is paying $1.8 million upfront to buy Bridge Health, to be followed by noncontingent quarterly ...

Novartis has ended work on ianalumab in a painful skin condition after the monoclonal antibody failed to meet “predefined ...

This story was updated at 5:30 p.m. ET to include comment from an investor call.   | Sarepta Therapeutics has laid off 500 staffers, or 36% of its workforce, as part of a strategic restructuring ...

Otsuka Pharmaceutical is putting down $33 million cash for a Swedish biotech’s IL1RAP antibodies designed to treat autoimmune ...

Following two rounds of pipeline prioritizations in a year, Repare reaffirmed this morning that it is focused on a pair of ...

One of the world’s biggest genetic databases comprises DNA data donated over the years by more than a million retired ...

Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...

Momentum in Johnson & Johnson’s cardiovascular business continues, while the company looks to regain its footing in the ...